Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Timeline

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Jun 23, 2023 5:49pm

268 Views

Post# 35512209

RE:Timeline

Eoga,

Didn't RW just say in the latest video interview? That we get ~100 treated by end of 2023/early 2024, then get it up for approval by FDA? IMO, this can only be done because TLT 'wants' to wait for 100 patients. Again, speculation, maybe the FDA said this to them? This would still require AA though right? To get this set up that early?

I guess this quote above is from the even more recent radio interview of RW? Haven't had the chance to listen yet.

Someone needs to politely ask at the AGM why not BTD/AA now? with perfectly good/great data ??

There must be a good reason?

<< Previous

Bullboard Posts

Next >>

The Market Online’s Weekly Gold Report – Nov. 27, 2024